Capricor Therapeutics Inc (CAPR)
R&D Expense Growth
5.44%
Quarterly · Period ending:
CAPR R&D Expense Growth
Latest reported5.44%period ending
Latest reported5.44%period ending
CAPR Quarterly R&D Growth (QoQ) (0.00% → 5.44%)
Latest values, visible window
High-resolution chart · PNG
CAPR r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 5.4403% | |
| 18.3474% | |
| 13.6233% | |
| -7.657% | |
| 16.5561% | |
| 29.9598% | |
| 23.2647% | |
| -5.5731% | |
| 12.6453% | |
| 11.6783% | |
| -0.8854% | |
| 13.7407% | |
| 15.0867% | |
| 22.9422% | |
| 13.2159% | |
| 10.8612% | |
| -2.9441% | |
| 19.9873% | |
| 69.5973% | |
| -28.1179% | |
| 6.0963% | |
| 20.08% | |
| 4.4057% | |
| 36.4101% | |
| 66.8582% | |
| 39.3855% | |
| -3.3826% | |
| -47.8246% | |
| -9.2214% | |
| -36.4338% | |
| -9.0358% | |
| -7.5834% | |
| 25.6581% | |
| 7.1088% | |
| 35.2309% | |
| -40.4731% | |
| -3.9607% | |
| 22.168% | |
| -43.6006% | |
| 9.7261% | |
| -0.7602% | |
| 30.3212% | |
| 4.322% | |
| -6.8281% | |
| -9.9816% | |
| 47.3297% | |
| 31.3676% | |
| 5.9806% | |
| 34.9818% | |
| -72.8636% | |
| 401.1869% | |
| -22.9421% | |
| 10.1595% | |
| 2,434.9055% | |
| -73.7728% | |
| -46.1146% | |
| -28.5596% | |
| -65.3239% | |
| -8.7075% | |
| 109.1247% | |
| 12.951% | |
| 10.5264% | |
| -50.9955% | |
| 8.8068% | |
| -19.5735% | |
| 47.6489% | |
| -22.6047% | |
| 4.1704% | |
| -16.7547% | |
| -35.4917% | |
| -19.6715% | |
| -11.4919% | |
| 46.0566% | |
| 29.535% | |
| -29.8254% | |
| 152.1352% | |
| 54.596% | |
| 0% | |
| -100% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |